The utility of micro RNAs as biomarkers in predicting progression and survival in patients with clear-cell renal cell carcinoma.

The article offers information on impact of biomarkers on cancer initiation and progression along with the utilization of microRNAs helps in directing clear-cell renal cell carcinoma (ccRCC) diagnosis and treatment. Topics discussed include need to predict accurate outcome and prognosis after treatment; differentiation between benign and ccRCC; and differential expression of biomarkers could delineate cancer status in biopsy specimens.